Tourmaline Bio
Sherry Beckman currently serves as the Director of Pharmacovigilance at Tourmaline Bio since March 2024, previously holding Director and Associate Director positions in Drug Safety and Pharmacovigilance at Biosplice Therapeutics from April 2019 to March 2024. Prior experience includes a Safety Specialist II role at Agility Clinical, Inc., where Sherry provided safety and pharmacovigilance services across biotech and pharmaceutical clinical trials. Sherry's background also encompasses environmental education coordination at Solana Center for Environmental Innovation, management of grants, and extensive nursing roles at Kaiser Permanente Medical Office and Hospital. Sherry earned a Bachelor's Degree from The Ohio State University.
This person is not in any teams
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.